Amoy Diagnostics Co., Ltd. Share Price
Equities
300685
CNE1000034D3
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.58 CNY | +0.36% |
|
-5.68% | -4.30% |
| Capitalization | 7.57B 1.1B 951M 861M 826M 1.51B 101B 1.57B 10.18B 4.07B 48.36B 4.13B 4.04B 173B | P/E ratio 2025 * |
21.3x | P/E ratio 2026 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise value | 6.64B 963M 833M 754M 724M 1.32B 88.45B 1.38B 8.92B 3.57B 42.38B 3.61B 3.54B 152B | EV / Sales 2025 * |
5.27x | EV / Sales 2026 * | 4.34x |
| Free-Float |
64.79% | Yield 2025 * |
1.35% | Yield 2026 * | 1.47% |
| 1 day | +0.36% | ||
| 1 week | -5.68% | ||
| Current month | -6.41% | ||
| 1 month | -8.08% | ||
| 3 months | -12.20% | ||
| 6 months | -21.02% | ||
| Current year | -4.30% |
| 1 week | 19.4 |  | 20.68 |
| 1 month | 19.4 | | 21.48 |
| Current year | 19.4 | | 23.56 |
| 1 year | 19.27 | | 26.15 |
| 3 years | 14.6 | | 30.39 |
| 5 years | 14.6 | | 61.39 |
| 10 years | 3.42 | | 61.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Min Luo
CEO | Chief Executive Officer | 43 | 30/11/2021 |
Ying Chen
DFI | Director of Finance/CFO | 56 | 31/03/2015 |
Hong Yu Wang
SAM | Sales & Marketing | 42 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Li Mou Zheng
CHM | Chairman | 73 | 20/02/2008 |
Hong Yu Wang
CHM | Chairman | 42 | 17/06/2015 |
Jie Min Luo
BRD | Director/Board Member | 43 | 12/08/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.36% | -5.68% | -16.32% | -34.16% | 1.1B | |
| -0.37% | -5.10% | -17.12% | +1.80% | 13B | |
| -0.47% | -5.50% | +117.02% | +188.59% | 12.14B | |
| -0.71% | +0.13% | -14.40% | -12.48% | 5.93B | |
| -3.22% | -0.10% | - | - | 5.43B | |
| -1.97% | +1.17% | -24.05% | +4.62% | 4.93B | |
| -0.35% | -3.82% | -28.22% | -39.24% | 4.29B | |
| -1.41% | +14.85% | +20.93% | +3.63% | 3.06B | |
| -0.41% | -4.92% | -17.62% | -45.29% | 2.85B | |
| -3.26% | -2.21% | +97.99% | -57.57% | 2.76B | |
| Average | -1.18% | -0.69% | +13.13% | +1.10% | 5.55B | |
| Weighted average by Cap. | -1.04% | -1.22% | +22.78% | +35.54% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.26B 183M 158M 143M 137M 250M 16.77B 261M 1.69B 676M 8.04B 685M 671M 28.81B | 1.46B 212M 184M 166M 160M 291M 19.49B 304M 1.97B 786M 9.34B 797M 780M 33.49B |
| Net income | 354M 51.41M 44.46M 40.26M 38.66M 70.5M 4.72B 73.61M 476M 190M 2.26B 193M 189M 8.11B | 413M 59.91M 51.81M 46.91M 45.04M 82.15M 5.5B 85.77M 555M 222M 2.64B 225M 220M 9.45B |
| Net Debt | -937M -136M -118M -107M -102M -187M -12.49B -195M -1.26B -504M -5.99B -511M -500M -21.46B | -1.23B -179M -155M -140M -135M -245M -16.43B -256M -1.66B -662M -7.87B -672M -657M -28.23B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/03/26 | 19.58 ¥ | +0.36% | 4,928,105 |
| 04/03/26 | 19.51 ¥ | -1.46% | 4,677,198 |
| 03/03/26 | 19.80 ¥ | -2.03% | 7,216,254 |
| 02/03/26 | 20.21 ¥ | -3.39% | 7,603,985 |
| 27/02/26 | 20.92 ¥ | +0.77% | 3,393,123 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300685 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition